Riverdale, NJ
18 Newark-Pompton Turnpike
Riverdale NJ 07457
Riverdale NJ 07457
mon-fri9:00 AM - 4:00 PM
saturdayClosed
sundayClosed
New Patients: For your convenience, please download, print out and complete the New Patient and Patient Medical History Forms and bring to your initial visit.
PATIENT FORMS
- RCCA New Patient Form
- General Consent for RCCA Services
- ACP Screener
- Pharmacy and Prescription Benefit Plan Information Form
- HIPAA acknowledgement
- Consultation Checklist & Radiology Policy
- New Jersey Immunization Information Systems (NJIIS) Consent to Participate
- Autorización de inscripción en el sistema de información sobre vacunación de nueva jersey
- Patient Finanical Assistance
Advanced Cancer Therapies in
Riverdale, NJ
If you or a loved one have recently been devastated by a cancer diagnosis, Regional Cancer Care Associates in Riverdale, NJ can help. Our physicians and oncologists work with you to determine the appropriate treatment plan based on your symptoms and medical history. We also provide cancer care support and financial advocacy services, to help you navigate the often-overwhelming journey towards cancer recovery.
In addition, Regional Cancer Care Associates also conducts regular clinical trials for new treatment and diagnosis methods. These are voluntary trials that further our understanding of cancer recovery and ensure a greater quality of life for future patients. Your fullest informed consent will be assured if you consider enrolling today.
Contact Us Today
Our Riverdale Regional Cancer Care Associates office is located at 18 Newark-Pompton Turnpike, Riverdale NJ 07457. Visit us today to schedule your appointment, or to ask us about our services. You can get in touch with us through our online form.
Our cancer treatment services include:
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.